Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 EUR | +0.33% | -1.28% | -2.22% |
05-20 | Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096 | CI |
03-06 | Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.22% | 33.74M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+2.18% | 22.67B | |
-10.09% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- HRTIS Stock
- News Herantis Pharma Oyj
- Herantis Pharma Plc Appoints Tone Kvåle as Chief Financial Officer